that facilitates covalent binding of penicillin to serum proteins. The factor(s) can be removed and then restored to increase penicillin binding to albumin. It appears that at least one component of the facilitation factor is less than 0.5 kDa, which suggests that it is not a peptide and that it is some simple serum component other than calcium or magnesium.
For 50 years, since its introduction, clinical use of penicillin has been complicated by immediate hypersensitivity reactions. Allergic reactions to penicillin have been reported to occur in 0.7 to 8% of patients, depending on the study (3) . We have previously reported that penicilloyl-specific immunoglobulin G (IgG) and IgE were detected in 38 and 18% of patients, respectively, who received >2 g of penicillin per day for at least 10 days (1), suggesting that major determinant-specific antibody responses are restricted to a minority of the general population. We postulated that heterogeneity of immune responsiveness to penicillin could be influenced by individual differences in immunogen formation and clearance, possibly involving differential rates of haptenation and dehaptenation to carrier serum proteins. Lee and Sullivan (2) have reported that penicillin haptenation to serum proteins is facilitated and not passive. Haptenation of penicillin to serum proteins was 4.0-to 5.3-fold greater than that to purified human serum albumin. Sullivan (4) has also reported that penicillin may undergo dehaptenation from albumin and that this process may proceed at a lower rate in penicillin-allergic subjects.
A number of questions remain regarding the nature of facilitated penicillin haptenation to serum proteins. Specifically, the kinetics of facilitated haptenation and the nature of facilitating serum factors need to be addressed. The objectives of this in vitro investigation were to extend the findings of Lee and Sullivan regarding facilitated haptenation (2) , to study the kinetics of haptenation further, and to determine the nature of facilitating factors. Each aliquot was treated as follows. To 110 RI of protein solution in which penicillin was incubated (serum or albumin), 1.5 ml of 3% trichloroacetic acid was added to precipitate proteins. The mixture was centrifuged (500 x g for 10 min at 20°C), and the supernatant was removed by vacuum. The precipitate was redissolved in 3 ml of PBS, and then protein was reprecipitated with 0.3 ml of 30% trichloroacetic acid. This redissolution-and-precipitation procedure was repeated a total of three times. The final protein pellet was dissolved in 150 ,ul of 0.5 N sodium hydroxide. The solution was placed in a scintillation vial, 4 ml of scintillation cocktail was added, and radioactivity was assayed with a beta counter and reported as counts per minute. All assays were performed in triplicate, and results were reported as means with standard deviations (SD). Background activity was determined from samples assayed as described above, except that precipitation and washing were initiated within 10 s of addition of labeled penicillin. For each test sample, the reported result in counts per minute is the net value of the counts per minute determined minus the background counts per minute.
A variety of protein-containing solutions were prepared and used in the experiments described below. These included the following: intact human serum; serum which had been concentrated by ultrafiltration (under nitrogen pressure) with a 30-or 10-kDa-cutoff membrane, washed with multiple volumes of PBS (diaflowed), and then reconstituted to the original volume with PBS; serum which had been concentrated by ultrafiltration with a 30-or 10-kDa-cutoff membrane, diaflowed, and then reconstituted to the original volume with serum ultrafiltrate (prepared with a 10-or 30-kDa-cutoff membrane); 4.6 or 7.2% human serum albumin (fraction V) diluted in PBS; 4.6% human serum albumin (fraction V) diluted in ultrafiltrate from serum (with a 10-or 30-kDa-cutoff membrane); 4.6% human serum albumin (crystallized and lyophilized fraction V) diluted in PBS; 4.6% human serum albumin (crystallized and lyophilized fraction V) diluted in ultrafiltrate from serum (with a 10-or 30 k-Dacutoff membrane); 4.6% human serum albumin (100% electrophoretically pure) diluted in PBS; 4.6% human serum albumin (100% electrophoretically pure) diluted in ultrafiltrate from serum (obtained with a 10-or 30-kDa-cutoff membrane); 2.6% IgG diluted in PBS, pH 7.4; and 2.6% IgG with human serum albumin (fraction V) in PBS, pH 7.4. For all albumin solutions, the pH was adjusted to 7.3 to 7.4. With the above-described protein solutions and procedures, a number of comparisons of serum, ultrafiltered serum, and albumin solutions were made.
Modification of penicillin binding to serum. An experiment was conducted to determine whether the putative factors responsible for increased penicillin binding could be removed from serum by ultrafiltration. The protein-containing solutions compared were intact serum, ultrafiltered serum diaflowed through a 30-kDa-cutoff membrane and reconstituted with PBS, and ultrafiltered serum diaflowed and reconstituted with serum ultrafiltrate (prepared with a 30-kDacutoff membrane). Labeled penicillin and unlabeled penicillin were added as described above, and the mixtures were incubated for 48 h.
The potency of the serum haptenation-facilitating factor(s) was assessed by reconstitution of serum that was ultrafiltered, diaflowed, and concentrated with serum ultrafiltrate (obtained with a 30-kDa-cutoff membrane) and PBS at various ratios (100, 75, 50, 25, and 0% ultrafiltrate) by using the incubation methods described above.
Characterization of haptenation facilitation factor(s). To characterize the haptenation-facilitating factor in serum, ultrafiltrate was prepared from intact serum by using membranes with molecular size cutoffs of 0.5, 10, 30, and 50 kDa. Serum that was ultrafiltered, diaflowed, and concentrated was then reconstituted by using each of these filtrates and compared with intact serum and 4.6% human serum albumin (fraction V) in PBS. The six test materials were studied by using the procedures described above and 48 h of incubation.
We then determined whether serum cations (calcium and magnesium) are the factors required for facilitated penicillin haptenation in 4.6% human serum albumin (fraction V) in PBS. The above-described procedures were followed for incubation and sample processing. Test materials included intact serum, 4.6% human serum albumin (fraction V) in PBS, 4.6% human serum albumin (fraction V) in PBS with 2.5 mM calcium (as calcium chloride), and 4.6% human serum albumin (fraction V) in PBS with 0.78 mM magnesium (as magnesium chloride). Serum that was ultrafiltered, diaflowed, and reconstituted with PBS was also tested by addition of 2.5 mM calcium or 0.78 mM magnesium.
Effect of albumin purity on penicillin binding. Since the fraction V human serum albumin used in the initial experiments was labeled as 96 to 99% pure, it was possible that non-albumin-haptenating factors from serum were present. Therefore, we determined whether albumin purity influences the extent to which penicillin binds. Three 4.6% human serum albumin products varying in purity were studied, i.e., fraction V, recrystallized and lyophilized fraction V, and 100% electrophoretically pure human serum albumin. Each was diluted in PBS and in serum ultrafiltrate (prepared from a 10-kDa-cutoff membrane), and the pH was adjusted to 7.3 to 7.4. The procedure described above was then followed, with the same amounts of labeled and unlabeled penicillin added, incubation time, wash and precipitation steps, and counting.
Haptenation kinetics. To investigate further the binding to intact serum and 100% pure human serum albumin reconstituted with serum ultrafiltrate, a kinetic study was done with seven determinations over the first 24 h.
RESULTS
Comparison of intact serum with 4.6% human serum albumin (fraction V in PBS). After incubation for 72 h with labeled penicillin, the mean binding of penicillin to intact serum was almost fivefold higher than with 4.6% human serum albumin (fraction V) (6,161 ± 1,272 versus 1,270 +-141 cpm). Binding of penicillin appeared to plateau by 24 h for both protein solutions (Fig. 1) . In a separate study (data not shown), when the human serum albumin concentration was increased to 7.2%, so that total protein concentrations were similar to that of intact serum, the extent of penicillin binding increased insignificantly, to 26% from 19.5% of the binding with intact serum. This suggests that there are factors in serum that enhance binding to albumin or that there are other substances in serum to which penicillin binds selectively.
In a related experiment, we determined whether immunoglobulin can account for the differences between penicillin binding to serum and penicillin binding to 4.6% human serum albumin. The protein solutions tested included intact serum, 4.6% human serum albumin (fraction V) in PBS, 4.6% human serum albumin (fraction V) with 2.6% IgG in PBS Characterization of haptenation factor(s). Reconstitution of serum with ultrafiltrate from 0.5-, 10-, 30-, and 50-kDa-cutoff membranes substantially increased penicillin binding compared with 4.6% albumin in PBS. The results are shown in Table 2 . This demonstrates that a major component of the haptenation activity is below 0.5 kDa. Addition of calcium or magnesium did not increase penicillin haptenation of human serum albumin or ultrafiltered and diaflowed serum. Penicillin binding was 6,287 + 341 cpm for intact serum, 2,188 + 98 cpm for human serum albumin without calcium or magnesium, 1,811 t 123 cpm for human serum albumin with calcium, and 1,772 ± 121 cpm for human serum albumin with magnesium. Binding of ultrafiltered and diaflowed serum was 3,791 ± 245 cpm with no added cations, 3,171 ± 65 cpm with calcium added, and 3,571 ± 58 cpm with magnesium added. Calcium and magnesium did not appear to be the facilitating factors.
Effect of albumin purity on penicillin binding. The extent to which penicillin bound to human serum albumin was directly related to albumin purity (Fig. 2) . For each type of albumin, dilution in serum ultrafiltrate increased the extent of binding almost twofold. With the purest human serum albumin diluted in serum ultrafiltrate, the extent of binding was equivalent to that of intact serum (data not shown). When 4.6% electrophoretically pure human serum albumin was diluted with ultrafiltrate from human serum albumin fraction V (obtained with a 10-kDa-cutoff membrane), penicillin binding was decreased compared with dilution with PBS (3,375 ± 54 versus 3,834 ± 89 cpm, respectively), suggesting that a factor in the fraction V human serum albumin preparation inhibited haptenation.
Haptenation kinetics. The relationship of penicillin binding with time is shown in Fig. 3 . By using linear regression to determine the slope of each line, we found average rates of binding to penicillin of 131 cpm/h for serum and 66 cpm/h for the human serum albumin solution. Therefore, the initial rate of binding to reconstituted purified human serum albumin was much less than the rate of binding to intact serum, suggesting that higher-molecular-weight factors in serum modulate penicillin haptenation.
Studies of sera from non-penicillin-allergic patients. Sera (Fig. 4) .
With the preparation of human serum albumin fraction V, much of the facilitation factor is removed while some of the inhibitory factors are not. Thus, the net effect with fraction V human serum albumin is a relatively low rate of penicillin haptenation. With further purification of human serum albumin, the inhibitory factors are removed, allowing facilitating factors to predominate. This is in agreement with the lower rate of haptenation with 100% pure human serum albumin in serum ultrafiltrate compared with intact serum. No direct relationship has been established between the extent of penicillin bound to serum proteins and the risk of penicillin allergy. Penicillin sensitivity also relates to mechanisms involved in antigen presentation and IgE production. However, even at some low level, production of penicilloylalbumin conjugate should be associated with reactivity since current models of type I hypersensitivity assume that bivalent penicilloyl-albumin is required to cross-link IgE on basophils or mast cells.
These studies support the hypothesis that there are factors in serum which facilitate and inhibit penicillin haptenation to serum proteins. Perhaps these factors could partially explain the heterogeneity of immune responsiveness to penicillin in patients, although this possibility was not investigated in our study. Further studies are needed to determine the relationship between facilitated haptenation and the immune response.
